Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, will discuss ABS resins for medical applications at its upcoming webinar on July 11, 2018 at 10:00 am EST. This is part of Trinseo’s webinar series designed to educate the marketplace on polymer technology and related topics.
Customers, media, and the general public can register now.
Trinseo has been providing polymers to global medical device manufacturers for nearly three decades and supports single and multiple use medical devices, drug delivery systems, and medical equipment housings with material solutions. The company has seen an increase in the use of ABS for medical devices because of benefits including processability, aesthetics, colorability, and toughness as well as potential customer cost savings opportunities.
Trinseo offers its ABS under the MAGNUM™ ABS Resins brand. MAGNUM™ ABS is distinct due to its mass polymerization technology that results in an exceptionally white base color, low gel levels, and low residual Volatile Organic Compounds (VOCs).These properties are especially critical in the medical devices sector where purity, quality of color, and surface finish are key.
Besides MAGNUM™ ABS Resins, Trinseo offers CALIBRE™ Polycarbonate Resins, EMERGE™ Advanced Resins, and STYRON™ Polystyrene Resins. Trinseo has a full portfolio of medical grade resins that have been tested for biocompatibility according to ISO 10993.
Trinseo is committed to quality and customers’ compliancy requirements in the highly-regulated medical space. Its medical manufacturing and compounding facilities at Stade, Germany, Hsinchu, Taiwan, and in North America as well as related global functions are ISO 13485:2016 certified with the latest 2016 version focused on risk management and process validation.
Trinseo (NYSE: TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, appliances, consumer electronics, medical devices, electrical, building and construction, textile, paper and board, footwear and tires. Trinseo had approximately $4.4 billion in net sales in 2017, with 16 manufacturing sites around the world, and approximately 2,200 employees. For more information visit www.trinseo.com
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release may include, without limitation, forecasts of growth, revenues, business activity, acquisitions, financings and other matters that involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. As a result of the foregoing considerations, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.